Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss (NCT07488039) | Clinical Trial Compass
RecruitingNot Applicable
Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss
Egypt21 participantsStarted 2026-01-01
Plain-language summary
The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are:
Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss?
Participants will:
undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome
Who can participate
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
* Franceschi types 2 and 3 labral defects
* subcritical glenoid bone loss \<20%
* positive anterior shoulder apprehension
Exclusion Criteria:
* Critical glenoid bones loss \>20%
* Franceschi type 1 labral defect
* concomitant long head of biceps tendon pathology
* multidirectional instability
* prior arthroscopic shoulder stabilization surgery
* concomitant proximal humeral fractures
* concomitant Rotator cuff tears
* skeletally immature patients
* glenoid pathology
* Shoulder arthritis
* active infection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Modified Rowe score postoperative
Timeframe: Assessed preoperative , then at 6 months and 12 months postoperative